A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Prevention Research

• Publication date

  2017-03-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1940-6207.CAPR-16-0167PMID 28325826PMCID PMC5503683
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancers of the Urinary System

  2014cited by this paper
• A Colorful Future for Quantitative Pathology: Validation of Vectra Technology Using Chromogenic Multiplexed Immunohistochemistry and Prostate Tissue Microarrays

  2012influential reference
• Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

  2010cited by this paper
• Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.

  2006cited by this paper
• Effects of Repeated Green Tea Catechin Administration on Human Cytochrome P450 Activity

  2006cited by this paper
• Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals

  2005cited by this paper
• Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBT‐II bladder tumour cell line

  2004influential reference
• The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.

  2004cited by this paper
• Glucuronides of tea catechins: enzymology of biosynthesis and biological activities.

  2003cited by this paper
• Tea intake, COMT genotype, and breast cancer in Asian-American women.

  2003cited by this paper
• Chemoprevention of superficial bladder cancer

  2003cited by this paper
• Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.

  2003cited by this paper
• Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate.

  2003cited by this paper
• Cancer therapy and prevention by green tea: role of ornithine decarboxylase

  2002cited by this paper
• Chemoprevention of superficial bladder cancer.

  2002cited by this paper
• Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.

  2001cited by this paper
• Ester Bond-containing Tea Polyphenols Potently Inhibit Proteasome Activity in Vitro and in Vivo *

  2001cited by this paper
• Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols

  2001cited by this paper
• Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.

  2001cited by this paper
• Tea consumption and risk of bladder and kidney cancers in a population-based case-control study.

  2000cited by this paper
• Inhibition of urinary bladder tumors induced by N‐butyl‐N‐(4‐hydroxybutyl)‐nitrosamine in rats by green tea

  1999influential reference
• Green tea in chemoprevention of cancer.

  1999cited by this paper
• Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase.

  1999cited by this paper
• Green tea and cancer in humans: a review of the literature.

  1998cited by this paper
• Chemoprotection: A review of the potential therapeutic antioxidant properties of green tea (Camellia sinensis) and certain of its constituents

  1997cited by this paper
• Tea consumption and cancer.

  1996cited by this paper
• Tea in chemoprevention of cancer.

  1996cited by this paper
• The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.

  1995cited by this paper
• Inhibition of oncogene expression by green tea and (-)-epigallocatechin gallate in mice.

  1995cited by this paper
• Green tea in chemoprevention of cancer.

  1992cited by this paper
• Biology and management of bladder cancer.

  1990cited by this paper
• Tea consumption and cancer.

  1988influential reference
• Case-control study of urinary bladder cancer in metropolitan Nagoya.

  1985cited by this paper
• Occupational and Environmental Cancers of the Urinary System

  1970cited by this paper

• Improved in vitro digestive stability of epicatechins in green tea infusion fermented by kombucha SCOBY

  2026cites this paper
• Nano-Engineered Epigallocatechin Gallate (EGCG) Delivery Systems: Overcoming Bioavailability Barriers to Unlock Clinical Potential in Cancer Therapy

  2025cites this paper
• Epigallocatechin gallate inhibit the protein arginine methyltransferase 5 and Enhancer of Zeste homolog 2 in breast cancer both in vitro and in vivo.

  2024cites this paper
• Plant bioactive compounds driven microRNAs (miRNAs): A potential source and novel strategy targeting gene and cancer therapeutics

  2024cites this paper
• Cellular and molecular mechanisms of action of epigallocatechin gallate on bladder cancer: A comprehensive systematic review

  2024cites this paper
• Ellagic acid: a potential inhibitor of enhancer of zeste homolog-2 and protein arginine methyltransferase-5

  2024cites this paper
• Factors driving the inter-individual variability in the metabolism and bioavailability of (poly)phenolic metabolites: A systematic review of human studies

  2024cites this paper
• The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy

  2024cites this paper
• Epigallocatechin-3-gallate inhibit the protein arginine methyltransferase 5 and Enhancer of Zeste homolog 2 in breast cancer both in vitro and in vivo

  2024cites this paper
• Pharmacodynamics and safety in relation to dose and response of plant flavonoids in treatment of cancers

  2024cites this paper
• Modulation of the ubiquitin‐proteasome system by phytochemicals: Therapeutic implications in malignancies with an emphasis on brain tumors

  2023cites this paper
• Phytochemical Small Molecules as Potential Anti-angiogenesis Targeted Therapy for Triple-Negative Breast Cancer

  2023cites this paper
• The potential of epigallocatechin gallate in the chemoprevention and therapy of hepatocellular carcinoma

  2023cites this paper
• Natural biomolecules and derivatives as anticancer immunomodulatory agents

  2023influential citation
• Epigallocatechin 3-gallate: From green tea to cancer therapeutics.

  2022cites this paper
• Therapeutic Effects of Green Tea Polyphenol (‒)-Epigallocatechin-3-Gallate (EGCG) in Relation to Molecular Pathways Controlling Inflammation, Oxidative Stress, and Apoptosis

  2022cites this paper
• Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy

  2022cites this paper
• Mitochondrial quality control proteases and their modulation for cancer therapy

  2022cites this paper
• Green Tea Catechins: Nature’s Way of Preventing and Treating Cancer

  2022cites this paper
• Modern aspects of the use of natural polyphenols in tumor prevention and therapy

  2022cites this paper
• Fibrosis in Mesothelioma: Potential Role of Lysyl Oxidases

  2022cites this paper
• Polyphenols as the Potential Disease-modifying Therapy in Cancer.

  2022cites this paper
• Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review

  2022cites this paper
• Polyphenols in foods: Classification, methods of identification, and nutritional aspects in human health.

  2021cites this paper
• Natural Phytochemicals in Bladder Cancer Prevention and Therapy

  2021cites this paper
• Phytochemicals intended for anticancer effects at preclinical levels to clinical practice: Assessment of formulations at nanoscale for non-small cell lung cancer (NSCLC) therapy

  2021cites this paper
• Cancer cell metabolic plasticity in migration and metastasis

  2021cites this paper
• Pharmacological Properties of Polyphenols: Bioavailability, Mechanisms of Action, and Biological Effects in In Vitro Studies, Animal Models, and Humans

  2021cites this paper
• Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways

  2021cites this paper
• Analytical Validation of Quantitative Pharmacodynamic Methods used in Clinical Cancer Studies

  2021cites this paper
• Implications of flavonoids as potential modulators of cancer neovascularity

  2020cites this paper
• Recent advances and possibilities for the use of plant phenolic compounds to manage ageing-related diseases

  2020cites this paper
• Part 1. Evaluation of epigallocatechin gallate or tannic acid formulations of hydrophobic drugs for enhanced dermal and bladder uptake or for local anesthesia effects.

  2020cites this paper
• Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer

  2020cites this paper
• Role of Curcumin and (−)-Epigallocatechin-3-O-Gallate in Bladder Cancer Treatment: A Review

  2020influential citation
• Applications of a Standardized Green Tea Catechin Preparation for Viral Warts and Human Papilloma Virus-Related and Unrelated Cancers

  2020cites this paper
• EGCG Mediated Targeting of Deregulated Signaling Pathways and Non-Coding RNAs in Different Cancers: Focus on JAK/STAT, Wnt/β-Catenin, TGF/SMAD, NOTCH, SHH/GLI, and TRAIL Mediated Signaling Pathways

  2020cites this paper
• The Potential for Reducing Lynch Syndrome Cancer Risk with Nutritional Nrf2 Activators

  2020cites this paper
• Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice

  2020cites this paper
• Epigenetic targeting of autophagy for cancer prevention and treatment by natural compounds.

  2020cites this paper
• Effects and mechanisms of tea for the prevention and management of cancers: An updated review

  2020cites this paper
• Microbial metabolites of flavanols in urine are associated with enhanced anti-proliferative activity in bladder cancer cells in vitro

  2020cites this paper
• Anticancer medicinal plants used by Moroccan people: Ethnobotanical, Preclinical, Phytochemical and Clinical evidence.

  2020cites this paper
• Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor

  2019cites this paper
• The immunomodulatory potential of natural compounds in tumor-bearing mice and humans

  2019cites this paper
• Gaze through the clinical lens: molecular and clinical advancements of botanicals.

  2019cites this paper
• Effects of Epigallocatechin Gallate (EGCG) on Urinary Bladder Urothelial Carcinoma―Next-Generation Sequencing and Bioinformatics Approaches

  2019cites this paper
• Untargeted/Targeted 2D Gas Chromatography/Mass Spectrometry Detection of the Total Volatile Tea Metabolome

  2019cites this paper
• Title Dietary natural flavonoids treating cancer by targeting aryl hydrocarbon receptor

  2019cites this paper
• Cerebral protection of epigallocatechin gallate (EGCG) via preservation of mitochondrial function and ERK inhibition in a rat resuscitation model

  2019cites this paper
• Thermal cycling-hyperthermia in combination with 1 polyphenols , epigallocatechin gallate and chlorogenic 2 acid , exerts synergistic anticancer effect against 3 human pancreatic cancer PANC-1 cells

  2019cites this paper
• Cerebral protection of epigallocatechin gallate (EGCG) via preservation of mitochondrial function and ERK inhibition in a rat resuscitation model

  2019cites this paper
• Investigational drugs currently in phase II clinical trials for actinic keratosis

  2019cites this paper
• Flavonoids as Potential Anticancer Agents in Clinics: Where Have We Reached So Far?

  2019cites this paper
• Current Aspects of Flavonoids: Their Role in Cancer Treatment

  2019cites this paper
• Thermal cycling-hyperthermia in combination with polyphenols, epigallocatechin gallate and chlorogenic acid, exerts synergistic anticancer effect against human pancreatic cancer PANC-1 cells

  2019cites this paper
• Tea, Coffee and Health Benefits

  2019cites this paper
• Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer

  2018cites this paper
• A Festschrift in Honor of Edward M. Messing, MD, FACS

  2018cites this paper
• Antimetabolic Effects of Polyphenols in Breast Cancer Cells: Focus on Glucose Uptake and Metabolism

  2018cites this paper